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Introduction
The NOD mouse strain has been widely used for investigating autoimmune disease and immune tolerance mechanisms (Pearson et al., 2016 ). An advantage of this strain is that it develops spontaneous autoimmune diabetes with many similarities to human type 1 diabetes (T1D) (Anderson and Bluestone, 2005; Wicker et al., 2005) . These include complex genetic susceptibility, the presence of autoreactive lymphocytes and shared disease pathology (Driver et al., 2011; Ridgway et al., 2008) . ESC technologies provide a proven strategy to generate genetically altered cell lines, differentiated cells and mice for studying molecular and cellular pathways in biological processes and disease pathogenesis (Gerlai, 2016) . However, derivation of useful germline competent ESCs from NOD mice has proved difficult using conventional methods (Brook et al., 2003; Nagafuchi et al., 1999) .
The discovery of ground-state culture conditions revealed that ESC derivation and maintenance are enabled by inhibition of GSK3 and/or ERK1/2, which suppresses residual differentiation (Sato et al., 2004; Umehara et al., 2007; Ying et al., 2008) . Subsequently, a few groups have generated NOD ESCs using different combinations of inhibitors: Hanna et al. used inhibitors of GSK3 and/or ERK1/2, but resultant ESCs required continuous presence of the inhibitors for stable expansion (Hanna et al., 2009 ); Nichols et al. also used two inhibitors (2i, one GSK3 inhibitor and one ERK1/2 inhibitor) (Nichols et al., 2009 ); whereas Ohta et al. reported using 3i (one GSK3 inhibitor and two ERK1/2 inhibitors) (Ohta et al., 2009 ). Previous studies have also shown that epigenetic remodeling increases the success rate of somatic cell nuclear transfer and generating induced pluripotent stem cells (iPSCs) and ESCs (Huangfu et al., 2008; Kim et al., 2009; Kishigami et al., 2007; Mikkelsen et al., 2008) . Nonetheless, it has not been reported if epigenetic remodeling can improve the derivation of stable NOD ESCs. In this study, we compared the effects of inhibiting GSK3 and epigenetic modifiers for establishing NOD ESC that do not require additional inhibitors for expansion and eventual derivation of NOD mice that develop spontaneous autoimmune diabetes. A blastocyst stage embryo from a NOD female at day-3.5 p.c. was plated on MEFs in a 96-well plate; (b) the embryo started hatching from the zona pellucida on the day after plating and (c) the whole hatched embryo attached to MEFs at day 3; (d) ICM outgrowth was formed at day 5 of culture; (e) the outgrowth was dissociated into single cells using trypsin at this stage and the first passage ESC colonies were expanded on new MEFs, and (f) split when 80% confluent to form the second passage colonies. (B) Phase and corresponding immunofluorescence staining images of pluripotency markers (NANOG and OCT4) in the two male ESC lines continuously cultured in medium supplemented with BIO for 14 and 16 passages for KOBIO-3 and KOBIO-10, respectively. (C) Phase and corresponding immunofluorescence staining images of pluripotency markers (NANOG and OCT4) in the two male ESC lines cultured in medium with BIO for first 3 passages and then without BIO for 11 and 13 passages for ESC lines respectively. (D) RT-PCR analysis of Oct4, Nanog and Rex1 in male NOD ESC lines. (E) Karyotyping of male ESC lines. (F) H&E staining of teratoma showing tissues from the three germ layers: (a) keratinized-epithelium (asterisk, ectoderm), (b) secreting-gland epithelium (arrow, endoderm) and neuro-rosette (asterisk, ectoderm), (c) cartilage (arrowhead, mesoderm), (d) smooth muscle (arrowhead, mesoderm) and tubule inner epithelium (endoderm).
Materials and methods

Mice
Mice were maintained in a pathogen-free facility under Monash University approved ethics (MMCAEC07/34).
Derivation of ESCs
Blastocysts were retrieved from 8-week-old NOD females, primed with 5 IU equine chorionic gonadotrophin (Folligon, Intervet) and 5 IU human chorionic gonadotrophin (Chorulon, Intervet) 48 h later, and subsequently mated with NOD males. Blastocysts were flushed from uteri using M2 medium (Sigma) at day-3.5 post coitum (p.c.). After washing with ESC medium, blastocysts were seeded in 96-well plates coated with mitotically-arrested mouse embryonic fibroblasts (MEFs) as feeder cells with ESC medium. MEF feeder cells and mouse ESC medium with 2000 IU LIF were prepared as described (Liu et al., 2011a; Liu et al., 2011b) . The following inhibitors alone or in combination were added: i) 0.2 μM AZA (Sigma), ii) 2 μM AZA, iii) 0.2 μM AZA and 20 nM TSA (Sigma), iv) 20 nM TSA, v) 1 μM VPA (Sigma), vi) 1 mM VPA, or vii) 2.5 μM BIO (Sigma). Blastocysts were also cultured in LIF-free ESC medium, supplemented with 2.5 μM BIO. During the first 4 days of culture, half the medium was refreshed every day to allow for hatching and attachment. At 5-7 days, outgrowths of inner cell masses (ICMs) were dissociated with 0.25% trypsin-ETDT (Invitrogen) and reseeded on feeder cells in 96-well plates. ESCs were grown to subconfluency and expanded in 6-well plates.
Characterization of ESC lines
Sex was determined by PCR detection of Jarid1c and Jarid1d as described (Clapcote and Roder, 2005) . Chromosome karyotyping, microsatellite genotyping, expression of Oct4, Nanog and Rex1 by RT-PCR and immunocytochemical staining, and differentiation capacity by teratoma formation were performed as described (Liu et al., 2011a) . Primer sequences are provided in Table S1 .
Generation of chimeras and germline transmission testing
Donor embryos were collected at the blastocyst stage from C57BL/6 (B6) females at day-3.5 p.c. 10-15 ESCs were injected into each blastocyst. After~2 h recovery period, injected blastocysts were transferred into the uterine horns of pseudopregnant B6 × CBA F1 females at day-2.5 p.c.. Chimeric mice were identified by coat color and male chimeras assessed for germline transmission by mating with wildtype NOD females.
Flow cytometry, insulitis and diabetes monitoring
Hematopoietic chimerism was assessed by flow cytometric analysis of splenic B cells as described (Liu et al., 2011a) . Insulitis scoring of pancreatic islets and detection of diabetes in mice were performed as described (Burt et al., 2010) .
Results
Derivation of stable NOD ESCs
LIF in combination with BIO, a single pharmacological inhibitor of GSK3, promoted ICMs to form cell-clump outgrowths ( Fig. 1Aa-d) . These outgrowths tolerated trypsin digestion to single cells, which proliferated to compacted colonies showing a 3D shape with a distinct glistening edge observed under phase contrast microscopy (Fig. 1Ae ). Cells were then split every 2-3 days at a 1:6 ratio (Fig. 1Af) . Ten NOD ESC lines were subsequently derived from twelve blastocysts (83% ,  Table S2 ), whereas we had previously obtained no NOD ESC lines even after plating up to 85 blastocysts in conventional ESC medium supplemented with LIF alone (Table S2) , a finding similar to other studies (Ohta et al., 2009 ). In contrast, LIF combined with the DNA methyltransferase inhibitor AZA and/or the histone deacetylase inhibitors TSA and VPA could not support ICM outgrowth formation, and no ESC lines were established (Table S2 ). We also tested BIO without LIF and found that most blastocysts formed ICM outgrowths. Putative ESC colonies were established from dissociated single cells (not shown). However, these colonies rapidly flattened out during successive passages, and no ESC line was derived (Table S2) . Two of the ten ESC lines established using BIO were male lines (KOBIO-3 and KOBIO-10) as determined by genotyping Jaridlc and Jaridld (Fig. S1 ). We subsequently chose the two male ESC lines for further studies because it was more efficient to generate offspring using male ESC lines than female ESC lines (ie chimeric males derived from a male ESC line can be mated with several females in succession to more rapidly generate a larger number of offspring for characterization). Male ESC lines also enable the Y chromosome to be investigated if needed. Both these male ESC lines were expanded to passage 3 in medium with BIO, and then expanded with or without BIO. After ten passages, ESC lines under both conditions maintained similar compacted colony morphology and relative celldoubling time, which is reflected by comparing the phase and corresponding immunofluorescence images (Fig. 1B, C) . Moreover, immunocytochemical staining showed that both cell lines, under either condition, expressed OCT4 and NANOG (Fig. 1B and C) . Further testing of the ESC lines maintained without BIO confirmed that they expressed Oct4, Nanog and Rex1 (Fig. 1D) , had a diploid karyotype (40, XY) ( Fig. 1E) and could differentiate based on teratoma formation analysis (Fig. 1F) . Additional genotyping of the KOBIO-10 line confirmed its NOD genetic background (Table S1 ).
Generation of chimeric mice and confirmation of germline transmission
Two NOD ESC lines were injected into B6 blastocysts that were then transferred into the uteri of pseudopregnant females. Thirteen chimeric mice were born (Table 1) , seven of which showed ≥50% coat color chimerism. We selected four chimeric males derived from KOBIO-10 with~95%,~90%,~80% and~50% coat color chimerism ( Fig. 2A) , and two chimeric males from KOBIO-3 with~50% chimerism (not shown) for germline transmission testing. Five chimeric mice produced albino progeny, indicating germline transmission competence (Table 1) . Moreover, three of the selected male chimeric mice generated from KOBIO-10 produced high efficient albino progeny ( Fig. 2A) , indicating KOBIO-10 is a high-quality ESC line efficient at producing ESCderived offspring. KOBIO-3 showed poorer germline transmission competency as one of the chimeric males sired three litters with no albino progeny.
We next assessed the hematopoietic chimerism of the chimeric mice generated from KOBIO-10 by expression of MHC class I and class II molecules on splenic B cells. Mouse 1 with~95% coat color chimerism showed > 75% hematopoietic chimerism (Fig. 2B) . However, the other chimeric males did not demonstrate a direct correlation between coat color and splenic B cell chimerism (Fig. 2B) . Mouse 2 and 3 had~90% and~80% coat color chimerism, but only 20% and 10% NOD-derived (caption on next page) splenic B cells, respectively. Lastly, mouse 4 had~50% coat color chimerism, but < 0.1% NOD-derived splenic B cells. To confirm that albino progeny were of NOD origin, splenocytes from three albinos and one agouti offspring from Mouse 1 (Fig. 2C) were analyzed by flow cytometry. The three albino mice only expressed NOD-derived MHC class I (K d ) and class II (I-A g7 ) molecules (Fig. 2D) . As expected, the agouti mouse expressed mixed MHC class I (K d and K b ) and mixed class II (I-A g7 and I-A b ) molecules indicating germline transmission from both NOD (i.e. female mother) and B6 (i.e. chimeric father) genetic backgrounds (Fig. 2D) .
Insulitis and diabetes in germline offspring
To assess NOD ESC-derived albino progeny for T1D susceptibility, we examined insulitis in albino male progeny and monitored diabetes onset in albino female progeny. Insulitis was present in all albino males at 8 weeks of age, and older males (18 weeks of age) exhibited increased insulitis; whereas insulitis was not detected in any agouti male progeny (Fig. 3A) . We also monitored a cohort of albino female progeny derived from both KOBIO-3 (n = 4) and KOBIO-10 (n = 19) NOD ESC lines. Notably, this ESC-derived cohort demonstrated a similar diabetes incidence compared to a cohort of wildtype NOD females (Fig. 3B) . Pancreatic histology of diabetic ESC-derived females also showed that their islets had extensive invasive insulitis and remnants of destroyed islets similar to wildtype NOD females (Fig. 3C ).
Discussion and conclusion
We show for the first time that BIO, a pharmacological inhibitor of GSK3, in combination with LIF, is sufficient to generate NOD ESC lines. Established male ESC lines expressed pluripotent markers, retained normal karyotypes, and were stable even in the absence of BIO during expansion. These lines also contributed to chimeric progeny after injection into B6 blastocysts with the majority of chimeric mice showing extensive coat color chimerism. Furthermore, both lines were capable of germline transmission to produce albino progeny that developed insulitis and spontaneous diabetes similar to wildtype NOD mice.
LIF was one of the first soluble factors identified to maintain mouse ESC pluripotency by acting downstream of the pospho-ERK pathway, which is stimulated by fibroblast growth factor-4 (FGF4), to block ESC differentiation (Ying et al., 2008) . Dual inhibition of FGF receptor and ERK signaling enabled self-renewal of ESCs, but led to progressive degeneration. Adding a GSK3 inhibitor restored viability and enabled expansion of undifferentiated ESCs (Ying et al., 2008) . Similar multiinhibitor approaches, as well as increasing LIF concentrations with serum-replacement, have been used to establish ESC lines from the nonpermissive NOD strain (Davies and Fairchild, 2012; Hanna et al., 2009; Nichols et al., 2009; Ohta et al., 2009 ), but there have been relatively few ensuing studies using ESC lines generated from these different methods to produce NOD mice that develop diabetes (Jakubczik et al., 2016; Morgan et al., 2013) .
To simplify NOD ESC derivation and stable expansion, as well as eliminate potential off-target side effects of inhibiting FGF receptor and ERK signaling (Kunath et al., 2007) , we tested BIO. This GSK3 inhibitor was reported to enhance ESC propagation and maintain pluripotency via activation of Wnt/β-catenin signaling (Sato et al., 2004; Umehara et al., 2007) . Notably, GSK3 is a serine/threonine kinase and a key regulator of Wnt/β-catenin signaling pathways. Upon GSK3 inhibition, non-phosphorylated β-catenin induces expression of Wnt-regulated genes (Willert and Jones, 2006) . However, recombinant Wnt3 alone induced non-neural differentiation, indicating canonical Wnt signal activation by itself is insufficient for maintaining ESC pluripotency (Willert and Jones, 2006) . Another study confirmed this finding, but showed that Wnt signal pathways could synergistically enhance LIF's effect to maintain ESC pluripotency (Ogawa et al., 2006) . Our results indicate that combining BIO alone with LIF not only contributes to maintaining viability, but also suppresses differentiation of NOD ESCs, even once BIO is removed during expansion. We also attempted to establish NOD ESC lines by remodeling global gene expression by altering DNA methylation and histone acetylation. AZA demethylates 5-methyl cytosines and prevents CpG binding protein activity, which was shown to be important for epigenetic modifications that favor ESC differentiation (Carlone et al., 2005) . Combining AZA with TSA, a histone deacetylase, was also shown to maintain persistent OCT4 expression and enhance derivation of ESCs from B6D2F1 × B6CBAF1 mice ). However, AZA alone or with TSA did not support NOD ESC derivation in our study. We also found that VPA, a histone deacetylase inhibitor that improves the efficiency of iPSC generation (Huangfu et al., 2008) , was unable to generate NOD ESCs either alone or with TSA. Therefore, targeting these global epigenetic modifiers seems unlikely to be useful for generating stable NOD ESCs. Notwithstanding, identification of specific epigenetic differences between ESCs derived from NOD and other mouse strains may help elucidate why certain strains are more permissive to derivation of stable ESC lines.
It has previously been reported that NOD ESCs are unstable unless maintained in the presence of inhibitors because their removal causes conversion of ESCs to EpiSCs (Hanna et al., 2009) . Our findings are not consistent with this observation; our NOD ESC lines were able to be expanded for at least 7 passages once BIO was removed. The pluripotent state of these cells was then stable with LIF alone in terms of gene expression, differentiation in vivo and in vitro, and capability of chimera production and germ line transmission. In summary, LIF combined with BIO, but not inhibitors of genetic remodeling, provides a simple and robust method to promote the derivation of stable pluripotent ESC lines from the non-permissive NOD mouse strain. The resulting NOD ESCs provide an additional resource for generating genetically altered cell lines, differentiated cells, and mice for investigating T1D pathogenesis.
